Heartflow Inc. (HTFL)
HTFL trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1464521/000146452126000042/0001464521-26-000042-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.
Profile
| Field | Value |
|---|---|
| Ticker | HTFL on Nasdaq |
| Sector | Health Care |
| Industry | Medical/Dental Instruments |
| Country | United States |
| IPO year | 2025 |
| SEC CIK | 0001464521 |
| SEC industry code | Surgical & Medical Instruments & Apparatus |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $176.0M |
| Net income | -$116.8M |
| Operating income | -$64.1M |
| Net margin | -66.3% |
| Operating margin | -36.4% |
| Revenue growth | +39.9% |
| Cash | $44.8M |
| Total assets | $359.5M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 23.4× |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | No going-concern finding. | 10-Q 2026-11-12 |
| Cash and burn | $31.6M cash; operating cash flow -$12.2M a quarter. | Report 2026-09-30 |
| Shares outstanding | 87,887,561 (2026-10-31); 85,158,719 a year earlier. | Cover page 2026-10-31 |
| Reverse splits, 3 years | None found | None on EDGAR |
| Shelf and offerings, 12 months | 0 S-3/F-3 shelf filings; 0 424B5 takedowns | None on EDGAR |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Auditor | PricewaterhouseCoopers LLP, San Jose, California, United States | PCAOB Form AP 2026-03-26 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $1.1M, sold $138.1M on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Quarterly results
| Quarter | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| Q3 2026 2026-09-30 | $72.9M | -$11.5M | $323K | $31.6M | No debt tags | $238.7M | 10-Q 2026-11-12 |
| Q2 2026 2026-06-30 | $64.1M | -$15.7M | -$8.6M | $34.4M | No debt tags | $212.1M | 10-Q 2026-08-13 |
| Q1 2026 2026-03-31 | $52.6M | -$27.4M | -$30.1M | $19.7M | No debt tags | $191.4M | 10-Q 2026-05-14 |
| Q4 2025 2025-12-31 | $49.1M | -$24.4M | -$10.6M | $44.8M | No debt tags | $176.0M | 10-K 2026-03-18 |
| Q3 2025 2025-09-30 | $46.3M | -$50.9M | -$3.0M | $291.2M | No debt tags | $161.9M | 10-Q 2026-11-12 |
| Q2 2025 2025-06-30 | $43.4M | -$9.2M | -$27.3M | $80.2M | $68.3M | $148.5M | 10-Q 2026-08-13 |
| Q1 2025 2025-03-31 | $37.2M | -$32.3M | -$13.2M | $109.8M | No debt tags | $136.2M | 10-Q 2026-05-14 |
| Q4 2024 2024-12-31 | $35.0M | -$33.0M | -$14.0M | $51.4M | $0 | $125.8M | 10-K 2026-03-18 |
From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B4 | 2025-08-08 |
| Latest annual report | 10-K | 2026-03-18 |
| Latest quarterly / interim | 10-Q | 2026-11-12 |
| Latest current report | 8-K | 2026-11-12 |
| Latest proxy | DEFA14A | 2026-04-29 |
Source: SEC EDGAR submissions feed, 204 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -7.5% |
| 1 month | -3.7% |
| 3 months | +56.3% |
| Year to date | +66.2% |
| 1 year | +56.6% |
| From 52-week high | -19.9% |
Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Medical/Dental Instruments
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| STVN | Stevanato Group S.p.A. | $15.53 | -1.71% | $4.2B |
| NVST | Envista Holdings Corporation | $24.03 | -1.88% | $3.9B |
| ICUI | ICU Medical Inc. | $181.87 | +1.45% | $4.5B |
| PLSE | Pulse Biosciences Inc Common Stock (DE) | $46.36 | -8.09% | $3.4B |
| MMSI | Merit Medical Systems Inc. | $86.35 | -0.32% | $5.2B |
| MMED | MiniMed Group Inc. | $18.65 | +3.67% | $5.2B |
| HAE | Haemonetics Corporation | $121.34 | -1.30% | $5.5B |
| IRTC | iRhythm Holdings Inc. | $90.83 | -1.18% | $3.1B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier